We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACIW icon
351
ACI Worldwide
ACIW
$5.61B
$322K 0.05%
14,000
– –
INCY icon
352
Incyte
INCY
$24B
$321K 0.05%
4,000
– –
WBD icon
353
Warner Bros
WBD
$66.2B
$319K 0.05%
33,632
– –
ALGN icon
354
Align Technology
ALGN
$12.1B
$316K 0.05%
1,500
– –
APLS
355
DELISTED
Apellis Pharmaceuticals
APLS
$310K 0.05%
+6,000
New +$318K
HQY icon
356
HealthEquity
HQY
$8.65B
$308K 0.05%
5,000
– –
BAX icon
357
Baxter International
BAX
$14B
$306K 0.05%
6,000
– –
OGS icon
358
ONE Gas
OGS
$5B
$303K 0.05%
4,000
– –
PARA
359
DELISTED
Paramount Global Class B
PARA
$302K 0.05%
17,887
– –
NTAP icon
360
NetApp
NTAP
$37.6B
$300K 0.05%
5,000
– –
STCN
361
DELISTED
Steel Connect, Inc. Common Stock
STCN
$300K 0.05%
22,500
– –
RIGL icon
362
Rigel Pharmaceuticals
RIGL
$733M
$300K 0.05%
20,000
– –
IPG
363
DELISTED
Interpublic Group of Companies
IPG
$300K 0.05%
9,000
– –
ROG icon
364
Rogers Corp
ROG
$2.39B
$298K 0.05%
2,500
– –
CEG icon
365
Constellation Energy
CEG
$93.2B
$293K 0.05%
3,400
– –
PEB icon
366
Pebblebrook Hotel Trust
PEB
$2.08B
$292K 0.05%
21,800
– –
VRTX icon
367
Vertex Pharmaceuticals
VRTX
$123B
$289K 0.05%
1,000
– –
SAFE
368
DELISTED
Safehold Inc.
SAFE
$286K 0.05%
10,000
– –
TRNO icon
369
Terreno Realty
TRNO
$7.2B
$284K 0.05%
5,000
– –
ADC icon
370
Agree Realty
ADC
$9.5B
$284K 0.05%
4,000
– –
NEWR
371
DELISTED
New Relic, Inc.
NEWR
$282K 0.05%
5,000
– –
UHS icon
372
Universal Health Services
UHS
$10.3B
$282K 0.05%
+2,000
New +$236K
CTRE icon
373
CareTrust REIT
CTRE
$9.72B
$279K 0.05%
15,000
– –
NXRT
374
NexPoint Residential Trust
NXRT
$636M
$279K 0.05%
6,400
– –
IFF icon
375
International Flavors & Fragrances
IFF
$21.6B
$277K 0.04%
2,640
– –
13 14
15
16 17

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.